08 Sep JangoBio adding staff, expanding testing capabilities
A Madison-based biotech startup with ambitious goals is adding staff and expanding testing capabilities as it seeks early-stage investment.
JangoBio is trying to develop regenerative therapy products which would diminish the effects of aging caused by imbalanced hormones. By regrowing certain tissues in the body, the company seeks to recreate the hormonal balance that slips away as people age.
Bill Kohl, COO for JangoBio, says the company’s hormone replacement therapies will “bring unparalleled improvements to health and well being.”
Sorry, the comment form is closed at this time.